Please use this identifier to cite or link to this item:
http://hdl.handle.net/1893/30567
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Li, Sheyu | en_UK |
dc.contributor.author | Nemeth, Imola | en_UK |
dc.contributor.author | Donnelly, Louise | en_UK |
dc.contributor.author | Hapca, Simona | en_UK |
dc.contributor.author | Zhou, Kaixin | en_UK |
dc.contributor.author | Pearson, Ewan R | en_UK |
dc.date.accessioned | 2019-12-20T01:03:33Z | - |
dc.date.available | 2019-12-20T01:03:33Z | - |
dc.date.issued | 2020-02-01 | en_UK |
dc.identifier.uri | http://hdl.handle.net/1893/30567 | - |
dc.description.abstract | OBJECTIVE To investigate the association between visit-to-visit HbA1c variability and cardiovascular events and microvascular complications in patients with newly diagnosed type 2 diabetes. RESEARCH DESIGN AND METHODS This retrospective cohort study analyzed patients from Tayside and Fife in the Scottish Care Information–Diabetes Collaboration (SCI-DC) who were observable from the diagnosis of diabetes and had at least five HbA1c measurements before the outcomes were evaluated. We used the previously reported HbA1c variability score (HVS), calculated as the percentage of the number of changes in HbA1c >0.5% (5.5 mmol/mol) among all HbA1c measurements within an individual. The association between HVS and 10 outcomes was assessed using Cox proportional hazards models. RESULTS We included 13,111–19,883 patients in the analyses of each outcome. The patients with HVS >60% were associated with elevated risks of all outcomes compared with the lowest quintile (for example, hazard ratios and 95% CIs [HVS >80 to ≤100 vs. HVS ≥0 to ≤20]: 2.38 [1.61–3.53] for major adverse cardiovascular events, 2.4 [1.72–3.33] for all-cause mortality, 2.4 [1.13–5.11] for atherosclerotic cardiovascular death, 2.63 [1.81–3.84] for coronary artery disease, 2.04 [1.12–3.73] for ischemic stroke, 3.23 [1.76–5.93] for heart failure, 7.4 [3.84–14.27] for diabetic retinopathy, 3.07 [2.23–4.22] for diabetic peripheral neuropathy, 5.24 [2.61–10.49] for diabetic foot ulcer, and 3.49 [2.47–4.95] for new-onset chronic kidney disease). Four sensitivity analyses, including adjustment for time-weighted average HbA1c, confirmed the robustness of the results. CONCLUSIONS Our study shows that higher HbA1c variability is associated with increased risks of all-cause mortality, cardiovascular events, and microvascular complications of diabetes independently of high HbA1c. | en_UK |
dc.language.iso | en | en_UK |
dc.publisher | American Diabetes Association | en_UK |
dc.relation | Li S, Nemeth I, Donnelly L, Hapca S, Zhou K & Pearson ER (2020) Visit-to-Visit HbA1c Variability Is Associated With Cardiovascular Disease and Microvascular Complications in Patients With Newly Diagnosed Type 2 Diabetes. Diabetes Care, 43 (2), pp. 426-432. https://doi.org/10.2337/dc19-0823 | en_UK |
dc.rights | Publisher policy allows this work to be made available in this repository. Published in Diabetes Care by American Diabetes Association. The original publication is available at: https://doi.org/10.2337/dc19-0823 Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license. | en_UK |
dc.rights.uri | https://storre.stir.ac.uk/STORREEndUserLicence.pdf | en_UK |
dc.subject | Internal Medicine | en_UK |
dc.subject | Endocrinology, Diabetes and Metabolism | en_UK |
dc.subject | Advanced and Specialised Nursing | en_UK |
dc.title | Visit-to-Visit HbA1c Variability Is Associated With Cardiovascular Disease and Microvascular Complications in Patients With Newly Diagnosed Type 2 Diabetes | en_UK |
dc.type | Journal Article | en_UK |
dc.identifier.doi | 10.2337/dc19-0823 | en_UK |
dc.identifier.pmid | 31727686 | en_UK |
dc.citation.jtitle | Diabetes Care | en_UK |
dc.citation.issn | 1935-5548 | en_UK |
dc.citation.issn | 0149-5992 | en_UK |
dc.citation.volume | 43 | en_UK |
dc.citation.issue | 2 | en_UK |
dc.citation.spage | 426 | en_UK |
dc.citation.epage | 432 | en_UK |
dc.citation.publicationstatus | Published | en_UK |
dc.citation.peerreviewed | Refereed | en_UK |
dc.type.status | AM - Accepted Manuscript | en_UK |
dc.contributor.funder | The Wellcome Trust | en_UK |
dc.citation.date | 14/11/2019 | en_UK |
dc.contributor.affiliation | Sichuan University | en_UK |
dc.contributor.affiliation | Ninewells Hospital & Medical School | en_UK |
dc.contributor.affiliation | Ninewells Hospital & Medical School | en_UK |
dc.contributor.affiliation | Ninewells Hospital & Medical School | en_UK |
dc.contributor.affiliation | University of the Chinese Academy of Sciences | en_UK |
dc.contributor.affiliation | Ninewells Hospital & Medical School | en_UK |
dc.identifier.isi | WOS:000508199900033 | en_UK |
dc.identifier.scopusid | 2-s2.0-85078389849 | en_UK |
dc.identifier.wtid | 1486333 | en_UK |
dc.contributor.orcid | 0000-0003-0060-0287 | en_UK |
dc.contributor.orcid | 0000-0003-3148-9657 | en_UK |
dc.contributor.orcid | 0000-0001-9237-8585 | en_UK |
dc.date.accepted | 2019-10-25 | en_UK |
dcterms.dateAccepted | 2019-10-25 | en_UK |
dc.date.filedepositdate | 2019-12-19 | en_UK |
rioxxterms.apc | not required | en_UK |
rioxxterms.type | Journal Article/Review | en_UK |
rioxxterms.version | AM | en_UK |
local.rioxx.author | Li, Sheyu|0000-0003-0060-0287 | en_UK |
local.rioxx.author | Nemeth, Imola| | en_UK |
local.rioxx.author | Donnelly, Louise| | en_UK |
local.rioxx.author | Hapca, Simona|0000-0003-3148-9657 | en_UK |
local.rioxx.author | Zhou, Kaixin| | en_UK |
local.rioxx.author | Pearson, Ewan R|0000-0001-9237-8585 | en_UK |
local.rioxx.project | Project ID unknown|The Wellcome Trust| | en_UK |
local.rioxx.freetoreaddate | 2019-12-19 | en_UK |
local.rioxx.licence | https://storre.stir.ac.uk/STORREEndUserLicence.pdf|2019-12-19| | en_UK |
local.rioxx.filename | Li_et_al_Diabetes_Care_Oct_2019_2-44.pdf | en_UK |
local.rioxx.filecount | 1 | en_UK |
local.rioxx.source | 1935-5548 | en_UK |
Appears in Collections: | Computing Science and Mathematics Journal Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Li_et_al_Diabetes_Care_Oct_2019_2-44.pdf | Fulltext - Accepted Version | 2.92 MB | Adobe PDF | View/Open |
This item is protected by original copyright |
Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/
If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.